Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 2/17/2019 |
| Start Date: | March 2014 |
| End Date: | December 31, 2019 |
Our hypothesis is that prophylactic administration of 5 days of Octreotide following EMR or
ampullectomy in patients with duodenal and ampullary adenomas greater than or equal to 10mm.
ampullectomy in patients with duodenal and ampullary adenomas greater than or equal to 10mm.
Inclusion Criteria:
Duodenal or ampullary adenoma greater than or equal to 10mm. Duodenal or ampullary adenoma
that is suitable for endoscopic mucosal resection.
Medically fit for anesthesia, endoscopy, and EMR Able to provide Informed Consent 18 years or
older, male and female
Exclusion criteria:
Duodenal or ampullary adenoma <10mm Duodenal or ampullary adenoma that is not suitable for
endoscopic mucosal resection Medically unfit for anesthesia, endoscopy, or EMR Unable to
provide Informed Consent Less than 18 years old Allergy to Octreotide
Duodenal or ampullary adenoma greater than or equal to 10mm. Duodenal or ampullary adenoma
that is suitable for endoscopic mucosal resection.
Medically fit for anesthesia, endoscopy, and EMR Able to provide Informed Consent 18 years or
older, male and female
Exclusion criteria:
Duodenal or ampullary adenoma <10mm Duodenal or ampullary adenoma that is not suitable for
endoscopic mucosal resection Medically unfit for anesthesia, endoscopy, or EMR Unable to
provide Informed Consent Less than 18 years old Allergy to Octreotide
Inclusion Criteria:
Duodenal or ampullary adenoma greater than or equal to 10mm Duodenal or ampullary adenoma
that is suitable for endoscopic mucosal resection Medically fit for anesthesia, endoscopy,
and EMR Able to provide Informed Consent 18 years or older, male and female
Exclusion Criteria:
Duodenal or ampullary adenoma <10mm Duodenal or ampullary adenoma that is not suitable for
endoscopic mucosal resection Medically unfit for anesthesia, endoscopy, or EMR Unable to
provide informed consent Less than 18 years old Allergy to Octreotide
We found this trial at
1
site
601 E Rollins St
Orlando, Florida 32803
Orlando, Florida 32803
(407) 303-5600
Principal Investigator: Robert Hawes, MD
Phone: 407-303-5503
Florida Hospital Florida Hospital is one of the country
Click here to add this to my saved trials
